Company intelligence / Profile preview
UNION therapeutics
Hellerup, Capital Region of Denmark, Denmarkuniontherapeutics.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
UNION therapeutics is a privately held, clinical-stage biopharmaceutical company focused on developing novel small molecule therapies for immunological diseases. Its lead candidate, orismilast—a next-generation PDE4B/D selective inhibitor—has shown promising efficacy and safety in mid-to-late stage clinical trials for atopic dermatitis, hidradenitis suppurativa, and psoriasis. The company has reported positive results from multiple Phase 2 studies and is preparing for further late-stage development with a focus on hidradenitis suppurativa due to strong mechanistic fit and early pain reduction benefits[2][5][8].
- Therapeutic areas
- GastroenterologyDermatologyInfectious Diseases
- Modalities
- Small moleculeSynthetic glucocorticoid corticosteroid (for specific programs)
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
Request access →03
Partnerships
Innovent Biologics (exclusive rights to oral orismilast and option on topical formulation in China/Hong Kong/Taiwan/Macau)
Beyond the preview
Go deeper on UNION therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on UNION therapeutics.